Lack of association between depressive symptoms and markers of immune and vascular inflammation in middle-aged men and women

Psychological Medicine

Volumn 33, Issue 4, 2003, Pages 667-674

  Steptoe, Andrew ^a   Kunz Ebrecht, S R ^a   Owen, N ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; B LYMPHOCYTE; CELL COUNT; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISTRESS SYNDROME; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; IMMUNE SYSTEM; INFLAMMATION; ISCHEMIC HEART DISEASE; MALE; NATURAL KILLER CELL; SYMPTOMATOLOGY; T LYMPHOCYTE;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DEPRESSIVE DISORDER; FEMALE; FIBRINOGEN; HUMANS; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-6; LEUKOCYTE COUNT; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; SIALOGLYCOPROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037855767     PISSN: 00332917     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0033291702007250     Document Type: Article

References (57)

1. Appels, A., Bar, F. W., Bar, J., Bruggeman, C. & de Baets, M. (2000). Inflammation, depressive symptomatology, and coronary artery disease. Psychosomatic Medicine 62, 601-605.
2. Baron, R. S., Cutrona, C. E., Hicklin, D., Russell, D. W. & Lubaroff, D. M. (1990). Social support and immune function among spouses of cancer patients. Journal of Personality and Social Psychology 59, 344-352.
3. Berk, M., Wadee, A. A., Kuschke, R. H. & O'Neill-Kerr, A. (1997). Acute phase proteins in major depression. Journal of Psychosomatic Research 43, 529-534.
4. Black, P. H. & Garbutt, L. D. (2002). Stress, inflammation and cardiovascular disease. Journal of Psychosomatic Research 52, 1-23.
5. Capuron, L., Ravaud, A., Gualde, N., Bosmans, E., Dantzer, R., Maes, M. & Neveu, P. J. (2001). Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology 26, 797-808.
6. Carney, R. M., Blumenthal, J. A., Stein, P. K., Watkins, L., Catellier, D., Berkman, L. F., Czajkowski, S. M., O'Connor, C., Stone, P. H. & Freedland, K. E. (2001). Depression, heart rate variability, and acute myocardial infarction. Circulation 104, 2024-2028.
7. Castle, S., Wilkins, S., Heck, E., Tanzy, K. & Fahey, J. (1995). Depression in caregivers of demented patients is associated with altered immunity. Clinical and Experimental Immunology 101, 487-493.
8. Chiappelli, F., Kung, M., Lee, P., Pham, L., Manfrini, E. & Villanueva, P. (1995). Alcohol modulation of human normal T-cell activation, maturation, and migration. Alcohol, Clinical and Experimental Research 19, 539-544.
9. Connor, T. J. & Leonard, B. E. (1998). Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sciences 62, 583-606.
10. Dantzer, R. (2001). Cytokine-induced sickness behavior: where do we stand? Brain, Behavior, and Immunity 15, 7-24.
11. Dentino, A. N., Pieper, C. F., Rao, M. K., Currie, M. S., Harris, T., Blazer, D. G. & Cohen, H. J. (1999). Association of interleukin-6 and other biologic variables with depression in older people living in the community. Journal of the American Geriatric Society 47, 6-11.
12. Elashoff, J. D. (2000). nQuery Advisor Release 4.0. Statistical Solutions Ltd: Cork, Ireland.
13. Ershler, W. B. & Keller, E. T. (2000). Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annual Review of Medicine 51, 245-270.
14. Everson, S. A., Kaplan, G. A., Goldberg, D. E. & Salonen, J. T. (2000). Hypertension incidence is predicted by high levels of hopelessness in Finnish men. Hypertension 35, 561-567.
15. Everson, S. A., Kaplan, G. A., Goldberg, D. E., Salonen, R. & Salonen, J. T. (1997). Hopelessness and 4-year progression of carotid atherosclerosis. The Kuopio Ischemic Heart Disease Risk Factor Study. Arteriosclerosis, Thrombosis and Vascular Biology 17, 1490-1495.
16. Ferketich, A. K., Schwartzbaum, J. A., Frid, D. J. & Moeschberger, M. L. (2000). Depression as an antecedent to heart disease among women and men in the NHANES I study. National Health and Nutrition Examination Survey. Archives of Internal Medicine 160, 1261-1268.
17. Gaffney, P. J. & Wong, M. Y. (1992). Collaborative study of a proposed international standard for plasma fibrinogen measurement. Thrombosis and Haemostasis 68, 428-432.
18. Glass, C. K. & Witztum, J. L. (2001). Atherosclerosis. The road ahead. Cell 104, 503-516.
19. Goldberg, D. (1972). Manual of the General Health Questionnaire. NFER-Nelson: Windsor.
20. Goldberg, D. & Williams, P. (1988). A User's Guide to the General Health Questionnaire. NFER-Nelson: Windsor.
21. Hansen, M. K., O'Conner, K. A., Goehler, L. E., Watkins, L. R. & Maier, S. F. (2001). The contribution of the vagus nerve in interleukin-1 beta-induced fever is dependent on dose. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 280, R929-934.
22. Heisel, J. S., Locke, S. E., Kraus, L. J. & Williams, R. M. (1986). Natural killer cell activity and MMPI scroes of a cohort of college students. American Journal of Psychiatry 143, 1382-1386.
23. Hemingway, H. & Marmot, M. (1999). Evidence based cardiology: psychosocial factors in the aetiology and prognosis of coronary heart disease: systematic review of prospective cohort studies. British Medical Journal 318, 1460-1467.
24. Herbert, T. B. & Cohen, S. (1993). Depression and immunity: a meta-analytic review. Psychological Bulletin 113, 472- 486.
25. Holsboer, F. (2000). The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23, 477-501.
26. Honig, A. & Maes, M. (2000). Psychoimmunology as a common pathogenetic pathway in myocardial infarction, depression and cardiac death. Current Opinion in Psychiatry 13, 661-664.
27. Irwin, M. (2002). Psychoneuroimmunology of depression: clinical implications. Brain, Behavior, and Immunity 16, 1-16.
28. Joyce, P. R., Hawes, C. R., Mulder, R. T., Sellman, J. D., Wilson, D. A. & Boswell, D. R. (1992). Elevated levels of acute phase plasma proteins in major depression. Biological Psychiatry 32, 1035-1041.
29. Jung, W. & Irwin, M. (1999). Reduction of natural killer cytotoxic activity in major depression: interaction between depression and cigarette smoking. Psychosomatic Medicine 61, 263-270.
30. Kiecolt-Glaser, J. K., McGuire, L., Robles, T. F. & Glaser, R. (2002). Emotions, morbidity, and mortality: new perspectives from psychoneuroimmunology. Annual Review of Psychology 53, 83-107.
31. Kop, W. J., Gottdiener, J. S., Tangen, C. M., Fried, L. P., McBurnie, M. A., Walston, J., Newman, A., Hirsch, C. & Tracy, R. P. (2002). Inflammation and coagulation factors in persons > 65 years of age with symptoms of depression but without evidence of myocardial ischemia. American Journal of Cardiology 89, 419-424.
32. Lamberts, S. W., van den Beld, A. W. & van der Lely, A. J. (1997). The endocrinology of aging. Science 278, 419-424.
33. Lesperance, F., Frasure-Smith, N., Juneau, M. & Theroux, P. (2000). Depression and 1-year prognosis in unstable angina. Archives of Internal Medicine 160, 1354-1360.
34. Lewthwaite, J., Owen, N., Coates, A., Henderson, B. & Steptoe, A. (2002). Circulating human heat shock protein 60 in the plasma of British civil servants. Circulation 106, 196-201.
35. Libby, P., Ridker, P. M. & Maseri, A. (2002). Inflammation and atherosclerosis. Circulation 105, 1135-1143.
36. Lutgendorf, S. K., Garand, L., Buckwalter, K. C., Reimer, T. T., Hong, S.-Y. & Lubaroff, D. M. (1999). Life stress, mood disturbance, and elevated interleukin-6 in healthy older women. Journal of Gerontology: Medical Sciences 54A, M434-M439.
37. McGuire, L., Kiecolt-Glaser, J. K. & Glaser, R. (2002). Depressive symptoms and lymphocyte proliferation in older adults. Journal of Abnormal Psychology 111, 192-197.
38. Maes, M. (1999). Major depression and activation of the inflammatory response system. Advances in Experimental Medicine and Biology 461, 25-46.
39. Maes, M., Scharpe, S., Bosmans, E., Vandewoude, M., Suy, E., Uyttenbroeck, W., Cooreman, W., Vandervorst, C. & Raus, J. (1992). Disturbances in acute phase plasma proteins during melancholia: additional evidence for the presence of an inflammatory process during that illness. Progress in Neuropsychopharmacology and Biological Psychiatry 16, 501-515.
40. Maes, M., Bosmans, E., De Jongh, R., Kenis, G., Vandoolaeghe, E. & Neels, H. (1997). Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 9, 853-858.
41. Marmot, M. G., Davey Smith, G., Stansfeld, S., Patel, C., North, F., Head, J., White, I., Brunner, E. & Feeney, A. (1991). Health inequalities among British civil servants: the Whitehall II study. Lancet 337, 1387-1393.
42. Mikova, O., Yakimova, R., Bosmans, E., Kenis, G. & Maes, M. (2001). Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. European Neuropsychopharmacology 11, 203-208.
43. Nemeroff, C. B. & Musselman, D. L. (2000). Are platelets the link between depression and ischemic heart disease? American Heart Journal 140, 57-62.
44. Newman, S. C., Bland, R. C. & Orn, H. (1988). A comparison of methods of scoring the General Health Questionnaire. Comprehensive Psychiatry 29, 402-408.
45. Penninx, B. W., Beekman, A. T., Honig, A., Deeg, D. J., Schoevers, R. A., van Eijk, J. T. & van Tilburg, W. (2001). Depression and cardiac mortality: results from a community-based longitudinal study. Archives of General Psychiatry 58, 221-227.
46. Rivest, S. (2001). How circulating cytokines trigger the neural circuits that control the hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinology 26, 761-788.
47. Rothermundt, M., Arolt, V., Peters, M., Gutbrodt, H., Fenker, J., Kersting, A. & Kirchner, H. (2001). Inflammatory markers in major depression and melancholia. Journal of Affective Disorders 63, 93-102.
48. Seidel, A., Arolt, V., Hunstiger, M., Rink, L., Behnisch, A. & Kirchner, H. (1995). Cytokine production and serum proteins in depression. Scandinavian Journal of Immunology 41, 534-538.
49. Sluzewska, A., Rybakowski, J., Bosmans, E., Sobieska, M., Berghmans, R., Maes, M. & Wiktorowicz, K. (1996). Indicators of immune activation in major depression. Psychiatry Research 64, 161-167.
50. Stansfeld, S. A., Sharp, D. S., Gallacher, J. E. & Yarnell, J. W. (1992). A population survey of ischaemic heart disease and minor psychiatric disorder in men. Psychological Medicine 22, 939-949.
51. Stansfeld, S. A., North, F. M., White, I. & Marmot, M. G. (1995). Work characteristics and psychiatric disorder in civil servants in London. Journal of Epidemiology and Community Health 49, 48-53.
52. Stansfeld, S. A., Head, J. & Marmot, M. G. (1998). Explaining social class differences in depression and well-being. Social Psychiatry and Psychiatric Epidemiology 33, 1-9.
53. Stansfeld, S. A., Fuhrer, R., Shipley, M. J. & Marmot, M. G. (2002). Psychological distress as a risk factor for coronary heart disease in the Whitehall II Study. International Journal of Epidemiology 31, 248-255.
54. Steptoe, A., Feldman, P. M., Kunz, S., Owen, N., Willemsen, G. & Marmot, M. (2002). Stress responsivity and socioeconomic status: a mechanism for increased cardiovascular disease risk? European Heart Journal 23, 1757-1763.
55. Steptoe, A., Kunz, S., Owen, N., Feldman, P. J., Rumley, A., Lowe, G. D. O. & Marmot, M. (2003). The influence of socioeconomic status and job control on plasma fibrinogen responses to acute mental stress. Psychosomatic Medicine (in the press).
56. Ziegelstein, R. C. (2001). Depression in patients recovering from a myocardial infarction. Journal of the American Medical Association 286, 1621-1627.
57. Zorrilla, E. P., Luborsky, L., McKay, J. R., Rosenthal, R., Houldin, A., Tax, A., McCorkle, R., Seligman, D. A. & Schmidt, K. (2001). The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain, Behavior, and Immunity 15,